Topical dorzolamide and metabolic acidosis in a neonate
- PMID: 12881361
- PMCID: PMC1771789
- DOI: 10.1136/bjo.87.8.1052
Topical dorzolamide and metabolic acidosis in a neonate
Figures
References
-
- Portellos M, Buckley EG, Freedman SF. Topical versus oral carbonic anhydrase inhibitor therapy for pediatric glaucoma. J AAPOS 1998:243–7. - PubMed
-
- DeLuise VP, Anderson DR. Primary infantile glaucoma (congenital glaucoma). Review. Surv Ophthalmol 1983;28:1–19. - PubMed
-
- Sugrue MF. Pharmacological and ocular hypotensive properties of topical carbonic anhydrase inhibitors. Progr Ret Eye Res 2000;19:87–112. - PubMed
-
- Strahlman E, Tipping R, Vogel R. The Dorzolamide Dose-response Study Group. A six-week dose-response study of the ocular hypotensive effect of dorzolamide with a one-year extension. Am J Ophthalmol 1996;122:183–94. - PubMed
-
- Biollaz J, Munafo A, Buclin T, et al. Whole-blood pharmacokinetics and metabolic effects of the topical carbonic anhydrase inhibitor dorzolamide. Eur J Clin Pharmacol 1995;47:453–60. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical